Precision Medicine World Conference

@PMWCintl

Leading precision medicine forum hosting the latest initiatives in & , est. 2009 Register for :

Silicon Valley, California
Vrijeme pridruživanja: siječanj 2011.

Medijski sadržaj

  1. BREAKING NEWS: American rises for the first time in four years due to improvements in mortality rates and decline in death from opioid overdose.

  2. A study found that the implementation of into clinical can provide accurate decision rules for the management of suspicious breast masses.

  3. The first cost-effectiveness analysis of CAR-T tisagenlecleucel compared with current standard care for pediatric patients with acute lymphoblastic leukemia (ALL) using a constructed population-based control arm.

  4. The next generation of -based methods will complement current methods, providing an insight into health and disease mechanisms.

  5. CMS MolDx finalized coverage for . Initially, the policy will only cover the Guardant360 assay if the patient has a recurrent, relapsed, refractory, metastatic, or advanced solid tumor that didn't originate from the CNS.

  6. Using checkpoint blockade therapies in the neoadjuvant setting presents a potential solution for de novo or acquired resistance in the adjuvant setting.

  7. Thank you Dr. for chairing a panel on "Implementing Precision Medicine in Hospitals" and for raising the very important Q: "Are we getting the medicines, the diagnostics, the interventions to those individuals that never make it to an academic medical center?"

  8. Molecular profile that includes data about the microbiome and genome, information about metabolites and proteins, and physiological measurements could reduce drug development cost and time.

  9. Study of rare variants in the exomes of more than 70,000 individuals. Justin Kao led a panel on scalable return of genomics, at the PMWC 2020 Silicon Valley.

  10. algorithms must show efficacy in robust clinical trials and in the real world to move into the next phase of clinical implementation. Dr. led a panel discussing those issues on Friday at .

  11. BREAKING NEWS: U.S. FDA released six new policies on gene therapy development aimed at encouraging pharmaceutical companies to bring new therapies to market.

  12. BREAKING NEWS: CMS expands coverage of Next Generation Sequencing as a diagnostic tool for patients with breast and ovarian cancer. CMS also gave Medicare contractors more leeway to use NGS for other cancers as well.

  13. For those that attended Dr. Raj Puri's session on Friday at the PMWC 2020 Silicon Valley, you can register for the FDA Individualized Therapeutics Workshop on March 3rd at:

  14. A prospective study of 1,190 patients found that by integrating whole-genome sequencing with advanced imaging and blood metabolites, researchers identified clinically significant findings associated with age-related chronic conditions.

  15. Venture capital and health system investors are bullish on digital health, patient engagement and genomics startups. As a result, among the most-funded startups are 23andMe with nearly $800M in funding, and with $520 million.

  16. You no longer can sit on the fence! The reports that rapid digitization of health records in recent years and privacy laws enabling companies to swap patient data, with potential for groundbreaking discoveries and lucrative products.

  17. New study reveals that the presence in tumours of two key immune components — B cells and tertiary lymphoid structures — is associated with favourable outcomes when individuals undergo immunotherapy. Hear more at .

  18. CEO Kevin reported at JPM 2020 that the firm sold 55 of its HD-X analyzers, adding to the 202 installed base for its HD-1 instrument. Hear more from Hrusovsky at .

  19. 's CEO, Sean George reported at JPM 2020 that the firm's volume of accessioned tests in 2019 grew to greater than 482,000, an impressive increase of 60% over the 303,000 tests in 2018. Hear from Tina Hambuch and other Invitae speakers at .

  20. "When we can bring together the best of the drug and diagnostic development world with the best and the brightest in the machine learning/AI world, then we truly work together as a team," ,

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·